IN Vitro Diagnostics (IVD) Market By Product Type (Reagents, Instruments, Software & Services), by Techniques (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Clinical Chemistry, Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Other Indications), Industry Trends, Estimation & Forecast, 2017 - 2025

IN Vitro Diagnostics (IVD) Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

A technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, directly derived from the human body to identify diseases, conditions and infections is called as In Vitro Diagnostics (IDV). The tests can be conducted in laboratories, hospital based laboratories and even point of care. Some major technologies which are amalgamated in vitro diagnostics include polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. Continuous innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.

Market Dynamics

Factors such as constantly increasing cases of chronic and infectious diseases, immunological disorders, and continuously rising geriatric population are driving the global IVD market growth. Moreover, emergence of minimal invasive technologies, increasing government initiatives and advancements in the IVD technology are pushing the market growth. However, stringent government regulations and lack of proper reimbursement policies in the developing countries are the major restraints to the IVD market growth. On the other hand, the emerging improvisations in the diagnostic technologies can act as a future opportunity to the market.

IN Vitro Diagnostics (IVD) Market Segmentation

By Product Type • Reagents • Instruments • Software & Services By Techniques     • Immunodiagnostics o Enzyme-Linked Immunosorbent Assay o Chemiluminescence Immunoassay o Fluorescence Immunoassay o Colorimetric Immunoassay o Colorimetric Immunoassay o Rapid Tests o Enzyme-Linked ImmunoSpot o Radioimmunoassay o Western blot • Blood Testing • Molecular Diagnostics o Polymerize Chain Reaction o Isothermal Nucleic Acid Technology o Hybridization o DNA diagnostics o Microarray o Others • Tissue Diagnostics • Clinical Chemistry o Basic metabolic panel o Liver panel o Lipid profile o Thyroid function panel o Electrolyte panel o Speciality chemicals • Other IVD Techniques By Application • Infectious Diseases • Cancer • Cardiac Diseases • Immune System Disorders • Nephrological Diseases • Gastrointestinal Diseases • Other Indications By End Users • Standalone Laboratory • Hospitals • Academic & Medical Schools • Point of Care • Others By Geography • North America o Canada o U.S o Mexico • Europe o Germany o France o U.K. o Others • Asia-Pacific o India o China o Japan o Australia o Others • LAMEA o Latin America o Middle East o Africa

Table of Content

• Affymetrix, Inc.
• Alere Inc.
• Biomerieux
• Danaher Corporation
• Roche Diagnostic
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Bayer AG.
• Arkray, Inc.
• Sysmex Corporation
• Johnson & Johnson Pvt Ltd.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS